Drug comparisons
Dapagliflozin vs Tolbutamide
Compare Dapagliflozin (SGLT2i Farxiga) vs Tolbutamide (sulfonylurea) for type 2 diabetes: efficacy, CV benefits, hypoglycemia risk, and weight effects.
No comparison dimensions are available for this page.
Clinical context
Patients or clinicians comparing an older sulfonylurea like Tolbutamide to a modern SGLT2 inhibitor like Dapagliflozin for type 2 diabetes treatment options.
Bottom line
Dapagliflozin is typically preferred over Tolbutamide due to superior cardiovascular outcomes and safety profile, though not a one-size-fits-all recommendation.
All medication comparisons